Qiu, X., Boufaied, N., Hallal, T., Feit, A., de Polo, A., Luoma, A., … Labbé, D. (2021). MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. bioRxiv. https://doi.org/10.1101/2021.04.23.441016

Qiu, Xintao, Nadia Boufaied, Tarek Hallal, Avery Feit, Anna de Polo, Adrienne Luoma, Janie Larocque, et al. “MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.” BioRxiv, 2021. https://doi.org/10.1101/2021.04.23.441016.

Qiu X, Boufaied N, Hallal T, Feit A, de Polo A, Luoma A, et al. MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. bioRxiv. 2021.

Qiu, Xintao, et al. “MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.” BioRxiv, 2021. Epmc, doi:10.1101/2021.04.23.441016.

Qiu X, Boufaied N, Hallal T, Feit A, de Polo A, Luoma A, Larocque J, Zadra G, Xie Y, Gu S, Tang Q, Zhang Y, Syamala S, Seo J-H, Bell C, O’Connor E, Liu Y, Schaeffer E, Karnes J, Weinmann S, Davicioni E, Cejas P, Ellis L, Loda M, Wucherpfennig K, Pomerantz M, Spratt D, Corey E, Freedman M, Liu S, Brown M, Long H, Labbé D. MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. bioRxiv. 2021.